Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Tissue engineering
- Historical perspective
- The culture of organs
- Biomedical devices and diagnostics industry: 2002
- Medical implant industry
- Tissue engineering and the implant industry
- Spare body parts
- Approved tissue products
- DERMAGRAFT on traumatic wounds
- Tissue engineered skin substitutes
- 8th annual hilton head workshop panel discussion
- Off-the-shelf availability
- Cell source can be a "show stopper"
- Use of autogous cells
- Use of allogeneic cells
- Embryonic stem cells
- "Flavors" of pluripotency exist
- Differentiation of embryonic stem cells
- Bone marrow-derived cells
- Scaffold strategies
- The matrix and cell function
- Cells in 2D configuration versus 3D configuration
- Bioreactor technology (1)
- Bioreactor technology (2)
- In vivo versus the in vitro bioreactor
- Development of a cell-seeded scaffold
- Integration into the living systems
- Some tissue engineering applications
- Combination products
- Therapeutic products
- What are some of the issues?
- Testing really begins after FDA approval
- Key industry trends since 2000
- Problems encountered by companies
- Advanced tissue sciences: a case study
- Status of industry: 2006
- Medtronic, inc.
- MG biotherapeutics
- Tissue engineering 2006
- Some research challenges
- Advances envisioned
- The industry of the future
Topics Covered
- Historical perspective
- Biomedical devices and diagnostics industry
- Medical implant industry
- Approved tissue products
- Dermagraft
- Tissue engineered skin substitutes
- Cell source
- Matrix
- Immune tolerance
- Off-the-shelf availability
- Embryonic stem cells
- Scaffolds
- Bioreactor technology
- Integration into the living system
- Therapeutic products
- Key industry trends
- Advances envisioned
Talk Citation
Nerem, R. (2007, October 1). Tissue engineering: the science, the technology and the industry [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/CPCC1093.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Robert Nerem has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Tissue engineering: the science, the technology and the industry
Published on October 1, 2007
27 min